Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis

Antimicrob Agents Chemother. 1989 Sep;33(9):1631-3. doi: 10.1128/AAC.33.9.1631.

Abstract

We reviewed tetracycline and erythromycin disk diffusion susceptibility of 457 isolates of Branhamella catarrhalis. Four isolates were resistant to tetracycline, with MICs for two available isolates of 16 micrograms/ml. Sixteen isolates were in the moderately susceptible range for erythromycin, with an MIC for one available isolate being greater than 8 micrograms/ml. These are the first tetracycline- and (by MIC) erythromycin-resistant B. catarrhalis isolates reported from the United States.

MeSH terms

  • Drug Resistance, Microbial
  • Erythromycin / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Moraxella catarrhalis / drug effects*
  • Moraxella catarrhalis / enzymology
  • Moraxella catarrhalis / genetics
  • Respiratory Tract Infections / microbiology
  • Tetracycline Resistance*
  • Tetracyclines / pharmacology
  • United States
  • beta-Lactamases / metabolism

Substances

  • Tetracyclines
  • Erythromycin
  • beta-Lactamases